Shares of O'Reilly Automotive Inc. (NASDAQ:ORLY), one of the largest retailers of aftermarket automotive parts, tools, and accessories, are popping 10% Thursday as of 12:17 p.m. EDT after announcing a strong first quarter and raising guidance.
Source: ThinkstockMay 17, 2018: The S&P 500 closed flat at 2,720.10. The DJIA closed down 0.2% at 24,714.05. Separately, the Nasdaq was down 0.2% at 7,382.47.
Thursday was a down day for the broad U.S. markets. Crude oil continued its progress although the dip was only marginal. The S&P 500 sectors were mostly split down the middle. The most positive sectors were energy and industrials,....More>>>
Conventional wisdom suggests that investors should find safe stocks to buy. Penny stocks and potential “triple-baggers” might be more exciting and a big win might provide a better story, but experts will tell you the smart play is to benefit from compounding returns in safe, stable stocks.
That general strategy is similar to that followed by Warren Buffett with Berkshire Hathaway....More>>>
Investors sold shares of Nvidia (NASDAQ:NVDA) on strength during trading on Monday. $1,037.80 million flowed into the stock on the tick-up and $1,228.77 million flowed out of the stock on the tick-down, for a money net flow of $190.97 million out of the stock. Of all companies tracked, Nvidia had the 2nd highest net out-flow for the day. Nvidia traded up $9.62 for the day and closed at $248.68
The S&P 500 Index took a slight breather this week as investors digested a mixed jobs report, tensions in Syria and minutes from the Federal Reserve that showed officials are open to cutting back the Fed’s balance sheet later this year, further reducing monetary stimulus. Despite some of the uncertainty, a handful of dividend stocks delivered clear messages with payout raises.
On Tuesday, our Under the Radar Moversnewsletter suggested shorting small cap pharmaceutical stock Esperion Therapeutics (NASDAQ: ESPR):
Esperion’s been on our list for a while not, and we finally got the clue we’ve been waiting on for a while. That is, a doji bar that’s noticeably out of character…. higher than the recent bars, in this case. Today’s move should....More>>>
DOL Wont Delay June 9 Fiduciary Rule Compliance Date: Acosta
Distributions Out of a Cash Value Life Insurance Policy
The administration of President Donald Trump has proposed a budget for fiscal year 2018 that could lead to increases in spending on major Affordable Care Act programs and on U.S. Department of Labor benefits compliance efforts.
GrubHub, Inc. (NYSE:GRUB) is an over-hyped growth stock whose growth prospects are misunderstood by the market. Despite big growth as a first-mover to the large online food and delivery service market, GRUB’s business model is defenseless despite its perceived “network effect.” GRUB’s projected growth runway will be eaten up by competing products from goliaths:....More>>>
July 7, 2017: Markets opened slightly higher Friday buoyed by a better-than-expected jobs report. The tech and consumer discretionary sectors led the gainers while the energy and telecom sectors were the laggards. WTI crude oil for August delivery settled at $44.23 a barrel, down 2.8% on the day and down 3.9% for the week following another increase in the oil and gas rig counts. August gold dropped....More>>>
With July 4th weekend upon us, here were the top 10 stocks with the highest social chatter and sentiment changes this week according to Stockal. Stockal tracks ratings and social data to gauge total sentiment on a stock. Keep an eye out for movement in this stocks next week as well.
1. Atlas Resource Partners, L.P. (NYSE: ARP) – ARP recorded a huge surge in price on Thursday.....More>>>
Orange (EPA:ORA) has been assigned a €20.00 ($24.69) price target by equities researchers at Barclays in a research report issued to clients and investors on Monday. The firm currently has a “buy” rating on the stock. Barclays’ price target indicates a potential upside of
CohBar, Inc. is a leader in the research and development of mitochondria based therapeutics (MBTs), an emerging class of drugs with the potential to treat a wide range of diseases associated with aging and metabolic dysfunction including non-alcoholic st
Shares ofGoPro (NASDAQ:GPRO) sank to fresh all-time lows on Monday, following an analyst downgrade (via Tech Trader Daily). Goldman Sachs analyst Simona Jankowski dropped her rating on GoPro from neutral to sell, while simultaneously slashing her price target down to a mere $6, or about 30% lower